National Institute on Drug Abuse
Overview
The National Institute on Drug Abuse (NIDA) is a United States federal government research institute that provides grants and funding for research on drug use and addiction.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Workit Health | Oct 2019 | Grant | Co-investor |
| Delix Therapeutics | Dec 2023 | Grant | Lead |
| Gilgamesh Pharma Inc. | Mar 2024 | Grant | Co-investor |
| WayBetter | - | Grant | Lead |
| RTM Vital Signs | Feb 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Institute on Drug Abuse based?
National Institute on Drug Abuse is headquartered in North Bethesda, Maryland, United States.
When was National Institute on Drug Abuse founded?
National Institute on Drug Abuse was founded in 1974.
How many portfolio companies does National Institute on Drug Abuse have?
National Institute on Drug Abuse has 33 portfolio companies in Caplight's dataset.
What are some companies in National Institute on Drug Abuse's portfolio?
Portfolio companies visible on Caplight include Workit Health, Delix Therapeutics, Gilgamesh Pharma Inc., WayBetter, RTM Vital Signs.
What was National Institute on Drug Abuse's most recent investment shown here?
National Institute on Drug Abuse's most recent investment in this portfolio sample was in Gilgamesh Pharma Inc. in 2024.
What sectors does National Institute on Drug Abuse focus on?
National Institute on Drug Abuse focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does National Institute on Drug Abuse focus on?
National Institute on Drug Abuse typically invests at the MultiStage stage.
What is National Institute on Drug Abuse's AUM?
National Institute on Drug Abuse's assets under management are estimated between $1.7B and $1.7B.